- Home
- TLSI vs STRS Comparison
TLSI vs STRS Comparison
Compare TLSI & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | STRS |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | 110 | N/A |
| Industry | Medical Specialities | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 244.2M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | TLSI | STRS |
|---|---|---|
| Price | $4.16 | $31.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 198.2K | 7.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 112.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $54,183,000.00 |
| Revenue This Year | $41.93 | N/A |
| Revenue Next Year | $41.75 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 213.74 |
| 52 Week Low | $3.42 | $15.28 |
| 52 Week High | $7.95 | $32.66 |
Technical Indicators
Market Signals| Indicator | TLSI | STRS |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 64.28 |
| Support Level | $3.61 | $18.22 |
| Resistance Level | $5.51 | N/A |
| Average True Range (ATR) | 0.39 | 1.11 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 7.22 | 79.72 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.